+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Infertility Treatment Market by Product, Procedure [ART, Insemination, Laparoscopy, Tubal Ligation], Patient Type, End User - Forecasts to 2023

  • ID: 4668354
  • Report
  • Region: Global
  • 177 Pages
  • Markets and Markets
1 of 5
The Infertility Treatment Market is Projected to Grow at a CAGR of 8.0% During the Forecast Period

FEATURED COMPANIES

  • Cook Group Incorporated
  • Genea Limited
  • Ihmedical A/S
  • Kitazato Corporation
  • Rocket Medical PLC
  • Thermo Fisher Scientific
  • MORE

Infertility Treatment Market by Product (Equipment, Media, Accessories), Procedure [ART (IVF, ICSI, Surrogate), Insemination, Laparoscopy, Tubal Ligation], Patient Type (Female, Male), End User (Fertility Clinics, Hospitals, Cryobanks) - Forecasts to 2023

The infertility treatment market is projected to grow at a CAGR of 8.0% during the forecast period.

The global infertility treatment market is projected to reach 2.2 billion by 2023 from USD 1.5 billion in 2018 at a CAGR of 8.0%. Growth in the infertility treatment market can be attributed to factors such as the declining fertility rate and increasing public awareness about various infertility treatment options. However, high procedural costs and unsupportive government regulations are the major factors restricting market growth.

The female infertility treatment segment is expected to hold the largest market share during the forecast period.

On the basis of patient type, the global infertility treatment market has been segmented into patient infertility treatment and male infertility treatment. The female infertility treatment segment is expected to hold the largest market share during the forecast period. Factors such as decreased rate of fertility in female population and increased range of available treatment options to overcome infertility issues are driving growth in this market segment.

The fertility centers segment is expected to grow at the highest rate during the forecast period.

On the basis of end user, the infertility treatment market is segmented into fertility centers, hospitals & surgical clinics, cryobanks, and research institutes. The fertility centers segment is expected to grow at the highest rate during the forecast period. This is mainly due to factors such as the increasing number of fertility centers across the globe and increasing medical tourism in emerging countries.
 
The European infertility treatment market is expected to hold the second-largest share during the forecast period.

Geographically, the infertility treatment market is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World. The Europe market is expected to hold the second-largest share during the forecast period. Growth in this segment is mainly due to the declining fertility rate, growing number of fertility clinics, and increasing number of public-private investments. Moreover, increasing medical tourism in various European countries such as Spain and Italy are also shifting the focus towards the European market, thereby driving the growth of this market during the forecast period.

Breakdown of supply-side primary interviews:

  • By Company Type: Tier 1 – 25%, Tier 2 – 30%, and Tier 3 – 45%
  • By Designation: C-level – 26%, Director-level – 30%, and Others – 44%
  • By Region: North America - 35%, Europe – 26%, APAC – 23%, and RoW – 16%

The major players in the market include The Cooper Companies Inc.  (US), Cook Group Incorporated (US), and Vitrolife AB (Sweden), Thermo Fisher Scientific, Inc. (US) Esco Micro Pte. Ltd. (Singapore), Genea Limited (Australia), IVFtech ApS (Denmark), Irvine Scientific (US), The Baker Company, Inc. (US), Kitazato (Japan), Rocket Medical Plc (UK), IHMedical A/S (Denmark), Hamilton Throne Ltd. (US), MedGyn Products, Inc. (US), ZEISS Group (Germany), and SOMATEX Medical Technologies GmbH (Germany).

Research Coverage
This report studies the infertility treatment market based on product, procedure, patient type, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro-markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.

Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, the market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the infertility treatment market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Cook Group Incorporated
  • Genea Limited
  • Ihmedical A/S
  • Kitazato Corporation
  • Rocket Medical PLC
  • Thermo Fisher Scientific
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
1.3.3 Years Considered for the Study
1.4 Currency
1.5 Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Breakdown of Primaries
2.1.3 Market Size Estimation
2.1.3.1 Product-Based Market Estimation
2.1.4 Primary Research Validation
2.2 Market Breakdown and Data Triangulation
2.2.1 Limitations
2.2.2 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Infertility Treatment Market: Overview
4.2 Geographic Analysis: Market, By Product
4.3 Asia Pacific: Market Share, By Procedure (2018)
4.4 Market, By Patient Type, 2018 vs 2023 (USD Million)
4.5 Market, By End User, 2018 vs 2023 (USD Million)
4.6 Geographical Snapshot of the Global Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Declining Fertility Rate
5.2.1.2 Rising Number of Fertility Clinics Worldwide
5.2.1.3 Technological Advancements
5.2.1.3.1 Advancements in Infertility Treatment Devices
5.2.1.3.1 Increase in the Use of Time-Lapse Technology
5.2.1.4 Increasing Public-Private Investments, Funds, and Grants
5.2.2 Restraints
5.2.2.1 High Procedural Cost of Assisted Reproductive Techniques in Developed Markets
5.2.2.2 Unsupportive Government Regulations
5.2.3 Opportunities
5.2.3.1 Growth Opportunities in Emerging Markets
5.2.3.1.1 Improving Healthcare Infrastructure
5.2.3.1.2 Increasing Medical Tourism Due to Low Treatment Costs
5.2.3.2 Use of Fertility Treatment Options By Single Parents and Same-Sex Couples
5.2.4 Challenges
5.2.4.1 Concerns Related to Art Procedures
5.2.4.2 Reduced Efficacy Among Older Women

6 Infertility Treatment Market, By Product
6.1 Introduction
6.2 Equipment
6.2.1 Microscopes
6.2.1.1 Growing Technological Advancements in the Field of Microscopy Resulting in the Growing Adoption of Microscopes
6.2.2 Imaging Systems
6.2.2.1 Emergence of Time-Lapse Imaging Systems Driving the Growth of the Infertility Treatment Imaging Systems Market
6.2.3 Sperm Analyzer Systems
6.2.3.1 Automated Sperm Analyzer Systems Permitting Internal and External Quality Control and Better Reproducibility
6.2.4 Ovum Aspiration Pumps
6.2.4.1 Ovum Aspiration Pumps Enable Smooth Collection of Oocytes During Infertility Treatment Procedures
6.2.5 Micromanipulator Systems
6.2.5.1 Micromanipulators are Commonly Used for the Treatment of Male Infertility, Particularly Cases Pertaining to Poor Sperm Quantity/Mobility
6.2.6 Incubators
6.2.6.1 Incubators Play A Vital Role in Embryo Development and Improved Clinical Outcomes
6.2.7 Gas Analyzers
6.2.7.1 Gas Analyzers Contain Multiple Ports Enabling Analysis of Sequential Gas Samples
6.2.8 Laser Systems
6.2.8.1 The Common Applications of Laser Systems Include Treament of Stress Urinary Incontinence and Vaginal Tightening
6.2.9 Cryosystems
6.2.9.1 Demand for Cryosystems is on the Rise as Women are Seeking to Extend Their Childbearing Years
6.3 Media & Consumables
6.3.1 Easy Availability of Culture Media Coupled With the Growing Awareness Among Individuals Driving the Growth of the Media & Consumables Segment
6.4 Accessories
6.4.1 Anti-Vibration Tables are Commonly Used for IVF Treatments to Provide A Smooth Workspace During Procedures

7 Infertility Treatment Market, By Procedure
7.1 Introduction
7.2 Assisted Reproductive Technology
7.2.1 in Vitro Fertilization
7.2.1.1 Intracytoplasmic Morphologically Selected Sperm Injection
7.2.1.1.1 Imsi is Highly Recommended in Patients With A Low Sperm Count and Recurrent Implantation Failure
7.2.1.2 Gamete Donation
7.2.1.2.1 Increase in the Number of Women Registering as Egg Donors is A Key Factor Aiding Market Growth
7.2.2 Intracytoplasmic Sperm Injection
7.2.2.1 Icsi is A Specialized Form of IVF Involving Fertilization Used Commonly in Male Infertility Treatment Procedures
7.2.3 Surrogacy
7.2.3.1 High Success Rates Guaranteed and Achieved With the Help of Surrogacy are Driving Market Growth
7.3 Artificial Insemination
7.3.1 Intrauterine Insemination
7.3.1.1 Limited Risk of Complications During Pregnancy and High Success Rates Driving Market Demand for Iui Procedures
7.3.2 Intracervical Insemination
7.3.2.1 Low Cost of Procedure as Compared to Other AI Procedures Leading to Increased Adoption
7.3.3 Intratubal Insemination
7.3.3.1 Better Chances of Successful Pregnancies Using Iti to Drive the Demand for This Procedure
7.4 Fertility Surgery
7.4.1 Laparoscopy
7.4.1.1 Laparoscopy Allows for the Biopsy of Suspect Growths and Cysts That Hamper Fertility
7.4.2 Hysteroscopy
7.4.2.1 Growing Demand for Minimally Invasive Procedures Driving the Adoption of Hysteroscopy Infertility Treatment Surgeries Globally
7.4.3 Myomectomy
7.4.3.1 Advantages of Myomectomy in Alleviating Problems Caused Due to Fibroids While Preserving Future Fertility to Drive the Demand for This Surgery
7.4.4 Laparotomy
7.4.4.1 Laparotomy is Used in Common Infertility Surgeries That Require Large Exposure to the Reproductive System
7.4.5 Tubal Ligation Reversal
7.4.5.1 Tubal Ligation Reversal is Performed Only in Women Who Still Have A Large Portion of Healthy Fallopian Tube Remaining
7.4.6 Varicocelectomy
7.4.6.1 Adoption of Varicocelectomy is High Among Patients and Results in A High Chance of Improved Fertility With Reduced Complications
7.4.7 Microsurgical Reconstruction
7.4.7.1 Vasovasostomy
7.4.7.1.1 Vasovasostomy is A Reversal Surgery Commonly Used in the Treatment of Infertility in Men
7.4.7.2 Vasoepididymostomy
7.4.7.2.1 Vasoepididymostomy Provides A Higher Pregnancy Rate Than IVF With Icsi
7.5 Other Infertility Treatment Procedures

8 Infertility Treatment Market, By Patient Type
8.1 Introduction
8.2 Female Infertility Treatment
8.2.1 Increasing Female Infertility Rates to Drive the Growth of the Female Infertility Treatment Market
8.3 Male Infertility Treatment
8.3.1 Growing Adoption of Male Infertility Treatment Procedures to Provide Potential Growth Opportunities

9 Infertility Treatment Market, By End User
9.1 Introduction
9.2 Fertility Centers
9.2.1 Growing Number of Infertility Treatment Centers Worldwide Driving Growth of This Segment
9.3 Hospitals and Surgical Clinics
9.3.1 Initiatives Undertaken By Governments to Increase the Number of Hospitals Equipped to Perform Infertility Treatment Procedures Contributing to Market Growth
9.4 Research Institutes
9.4.1 Growing Need for Improving the Clinical Efficacy of Various Infertility Treatment Options Driving Market Growth in Research Institutes
9.5 Cryobanks
9.5.1 Increasing Number of Art Procedures Using Donor Sperm and Donor Eggs for Infertility Treatment Driving the Demand for Cryobanks

10 Infertility Treatment Market, By Region
10.1 Introduction
10.2 North America
10.2.1 Us
10.2.1.1 US to Dominate the Infertility Treatment Market in North America
10.2.2 Canada
10.2.2.1 Government Initiatives and Legislations for Same-Sex Marriages to Drive Market Growth in Canada
10.3 Europe
10.3.1 Germany
10.3.1.1 Favorable Funding Scenario for IVF Treatments in Germany to Drive the Growth of the Infertility Treatment Market in the Country
10.3.2 Uk
10.3.2.1 Increase in the Number of IVF Cycles in the UK Contributing to Market Growth
10.3.3 France
10.3.3.1 The Art Segment Dominated the Infertility Treatment Procedures Market in France
10.3.4 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.1.1 Growing Awareness has Served to Boost the Adoption of IVF Procedures in Japan
10.4.2 China
10.4.2.1 Declining Newborn Population and Birth Rate in China to Drive the Demand for Infertility Treatment Procedures in the Country
10.4.3 India
10.4.3.1 Rising Fertility Medical Tourism Offering High-Growth Opportunities for the Infertility Treatment Market in India
10.4.4 Rest of Asia Pacific
10.5 Rest of the World
10.5.1 Latin America
10.5.1.1 Latin America to Account for the Largest Share of the Rest of the World Infertility Treatment Market
10.5.2 Middle East & Africa
10.5.2.1 Rising Incidence of Male-Factor Infertility to Drive Market Growth During the Forecast Period

11 Competitive Landscape
11.1 Overview
11.2 Infertility Treatment: Market Share Analysis, 2017
11.3 Competitive Scenario

12 Company Profiles
(Business Overview, Products Offered, Recent Developments, MnM View)*
12.1 Cook Group Incorporated
12.2 Esco Micro Pte. Ltd.
12.3 Genea Limited
12.4 Hamilton Throne, Ltd.
12.5 Ihmedical A/S
12.6 Irvine Scientific (A Member of Jx Holdings Group)
12.7 IVFTech Aps
12.8 Kitazato Corporation
12.9 Medgyn Products, Inc.
12.10 Rocket Medical PLC
12.11 Somatex Medical Technologies GmbH
12.12 The Baker Company, Inc.
12.13 The Cooper Companies, Inc.
12.14 Thermo Fisher Scientific
12.15 Vitrolife Ab
12.16 Zeiss Group

*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.

13 Appendix
13.1 Discussion Guide
13.2 Knowledge Store: Subscription Portal
13.3 Available Customizations
13.4 Related Reports
13.5 Author Details

List of Tables
Table 1 Infertility Treatment Market, By Product, 2016–2023 (USD Million)
Table 2 Infertility Treatment Equipment Market, By Type, 2016–2023 (USD Million)
Table 3 Infertility Treatment Equipment Market, By Region, 2016–2023 (USD Million)
Table 4 Microscopes Market, By Region, 2016–2023 (USD Million)
Table 5 Imaging Systems Market, By Region, 2016–2023 (USD Million)
Table 6 Sperm Analyzer Systems Market, By Region, 2016–2023 (USD Million)
Table 7 Ovum Aspiration Pumps Market, By Region, 2016–2023 (USD Million)
Table 8 Micromanipulator Systems Market, By Region, 2016–2023 (USD Million)
Table 9 Incubators Market, By Region, 2016–2023 (USD Million)
Table 10 Gas Analyzers Market, By Region, 2016–2023 (USD Million)
Table 11 Laser Systems Market, By Region, 2016–2023 (USD Million)
Table 12 Cryosystems Market, By Region, 2016–2023 (USD Million)
Table 13 Media & Consumables Market, By Region, 2016–2023 (USD Million)
Table 14 Accessories Market, By Region, 2016–2023 (USD Million)
Table 15 Infertility Treatment Market, By Procedure, 2016-2023 (USD Million)
Table 16 Assisted Reproductive Technology Market, By Type, 2016–2023 (USD Million)
Table 17 Assisted Reproductive Technology Market, By Region, 2016–2023 (USD Million)
Table 18 in Vitro Fertilization Market, By Region, 2016–2023 (USD Million)
Table 19 Intracytoplasmic Sperm Injection Market, By Region, 2016–2023 (USD Million)
Table 20 Surrogacy Market, By Region, 2016–2023 (USD Million)
Table 21 Artificial Insemination Market, By Type, 2016–2023 (USD Million)
Table 22 Artificial Insemination Market, By Region, 2016–2023 (USD Million)
Table 23 Fertility Surgery Market, By Type, 2016–2023 (USD Million)
Table 24 Fertility Surgery Market, By Region, 2016–2023 (USD Million)
Table 25 Other Infertility Treatment Procedures Market, By Region, 2016–2023 (USD Million)
Table 26 Infertility Treatment Market, By Patient Type, 2016–2023 (USD Million)
Table 27 Female Infertility Treatment Market, By Region, 2016–2023 (USD Million)
Table 28 Male Infertility Treatment Market, By Region, 2016–2023 (USD Million)
Table 29 Market, By End User, 2016–2023 (USD Million)
Table 30 Market for Fertility Clinics, By Region, 2016–2023 (USD Million)
Table 31 Infertility Treatment Devices Market for Hospitals and Surgical Clinics, By Region, 2016–2023 (USD Million)
Table 32 Market for Research Institutes, By Region, 2016–2023 (USD Million)
Table 33 Market for Cryobanks, By Region, 2016–2023 (USD Million)
Table 34 Market, By Region, 2016–2023 (USD Million)
Table 35 North America: Infertility Treatment Market, By Country, 2016–2023 (USD Million)
Table 36 North America: Market, By Procedure, 2016–2023 (USD Million)
Table 37 North America: Market, By Product, 2016–2023 (USD Million)
Table 38 North America: Market, By Patient Type, 2016–2023 (USD Million)
Table 39 North America: Market, By End User, 2016–2023 (USD Million)
Table 40 US: Infertility Treatment Market, By Procedure, 2016–2023 (USD Million)
Table 41 US: Market, By Product, 2016–2023 (USD Million)
Table 42 US: Market, By End User, 2016–2023 (USD Million)
Table 43 US: Market, By Patient Type, 2016–2023 (USD Million)
Table 44 Canada: Infertility Treatment Market, By Procedure, 2016–2023 (USD Million)
Table 45 Canada: Market, By Product, 2016–2023 (USD Million)
Table 46 Canada: Market, By End User, 2016–2023 (USD Million)
Table 47 Canada: Market, By Patient Type, 2016–2023 (USD Million)
Table 48 Europe: Infertility Treatment Market, By Country, 2016–2023 (USD Million)
Table 49 Europe: Market, By Procedure, 2016–2023 (USD Million)
Table 50 Europe: Market, By Product, 2016–2023 (USD Million)
Table 51 Europe: Market, By Patient Type, 2016–2023 (USD Million)
Table 52 Europe: Market, By End User, 2016–2023 (USD Million)
Table 53 Germany: Infertility Treatment Market, By Procedure, 2016–2023 (USD Million)
Table 54 Germany: Market, By Product, 2016–2023 (USD Million)
Table 55 Germany: Market, By Patient Type, 2016–2023 (USD Million)
Table 56 Germany: Market, By End User, 2016–2023 (USD Million)
Table 57 UK: Infertility Treatment Market, By Procedure, 2016–2023 (USD Million)
Table 58 UK: Market, By Product, 2016–2023 (USD Million)
Table 59 UK: Market, By Patient Type, 2016–2023 (USD Million)
Table 60 UK: Market, By End User, 2016–2023 (USD Million)
Table 61 France: Infertility Treatment Market, By Procedure, 2016–2023 (USD Million)
Table 62 France: Market, By Product, 2016–2023 (USD Million)
Table 63 France: Market, By Patient Type, 2016–2023 (USD Million)
Table 64 France: Market, By End User, 2016–2023 (USD Million)
Table 65 RoE: Infertility Treatment Market, By Procedure, 2016–2023 (USD Million)
Table 66 RoE: Market, By Product, 2016–2023 (USD Million)
Table 67 RoE: Market, By End User, 2016–2023 (USD Million)
Table 68 RoE: Market, By Patient Type, 2016–2023 (USD Million)
Table 69 APAC: Infertility Treatment Market, By Country, 2016–2023 (USD Million)
Table 70 APAC: Market, By Procedure, 2016–2023 (USD Million)
Table 71 APAC: Market, By Product, 2016–2023 (USD Million)
Table 72 APAC: Market, By Patient Type, 2016–2023 (USD Million)
Table 73 APAC: Market, By End User, 2016–2023 (USD Million)
Table 74 Japan: Infertility Treatment Market, By Procedure, 2016–2023 (USD Million)
Table 75 Japan: Market, By Product, 2016–2023 (USD Million)
Table 76 Japan: Market, By Patient Type, 2016–2023 (USD Million)
Table 77 Japan: Market, By End User, 2016–2023 (USD Million)
Table 78 China: Infertility Treatment Market, By Procedure, 2016–2023 (USD Million)
Table 79 China: Market, By Product, 2016–2023 (USD Million)
Table 80 China: Market, By Patient Type, 2016–2023 (USD Million)
Table 81 China: Market, By End User, 2016–2023 (USD Million)
Table 82 India: Infertility Treatment Market, By Procedure, 2016–2023 (USD Million)
Table 83 India: Market, By Product, 2016–2023 (USD Million)
Table 84 India: Market, By Patient Type, 2016–2023 (USD Million)
Table 85 India: Market, By End User, 2016–2023 (USD Million)
Table 86 RoAPAC: Infertility Treatment Market, By Procedure, 2016–2023 (USD Million)
Table 87 RoAPAC: Market, By Product, 2016–2023 (USD Million)
Table 88 RoAPAC: Market, By Patient Type, 2016–2023 (USD Million)
Table 89 RoAPAC: Market, By End User, 2016–2023 (USD Million)
Table 90 RoW: Infertility Treatment Market, By Country, 2016–2023 (USD Million)
Table 91 RoW: Market, By Procedure, 2016–2023 (USD Million)
Table 92 RoW: Market, By Product, 2016–2023 (USD Million)
Table 93 RoW: Market, By Patient Type, 2016–2023 (USD Million)
Table 94 RoW: Market, By End User, 2016–2023 (USD Million)
Table 95 Latin America: Infertility Treatment Market, By Procedure, 2016–2023 (USD Million)
Table 96 Latin America: Market, By Product, 2016–2023 (USD Million)
Table 97 Latin America: Market, By Patient Type, 2016–2023 (USD Million)
Table 98 Latin America: Market, By End User, 2016–2023 (USD Million)
Table 99 Middle East & Africa: Infertility Treatment Market, By Procedure, 2016–2023 (USD Million)
Table 100 Middle East & Africa: Market, By Product, 2016–2023 (USD Million)
Table 101 Middle East & Africa: Market, By Patient Type, 2016–2023 (USD Million)
Table 102 Middle East & Africa: Market, By End User, 2016–2023 (USD Million)
Table 103 Product Launches and Enhancements
Table 104 Expansions
Table 105 Collaborations, Partnerships, and Agreements
Table 106 Acquisitions

List of Figures
Figure 1 Infertility Treatment Market: Research Methodology Steps
Figure 2 Research Design
Figure 3 Bottom-Up Approach Market Size Estimation: Infertility Treatment Market
Figure 4 Top-Down Approach Market Size Estimation: Infertility Treatment Market
Figure 5 Data Triangulation Methodology
Figure 6 Infertility Treatment Market, By Procedure, 2018 vs 2023 (USD Million)
Figure 7 Market Share, By Product, 2018
Figure 8 Market Share, By Patient Type, 2018
Figure 9 Market, By End User, 2018 vs 2023 (USD Million)
Figure 10 Geographic Snapshot of the Infertility Treatment Market
Figure 11 Declining Global Fertility Rate—Major Factor Driving Market Growth
Figure 12 Media & Consumables Market in the Asia Pacific to Register the Highest Growth Rate During the Forecast Period
Figure 13 Assisted Reproductive Technology Segment to Dominate the Asia Pacific Infertility Treatment Market in 2018
Figure 14 Female Infertility Treatment Segment Will Continue to Dominate the Global Market in 2023
Figure 15 Fertility Centers to Dominate the Infertility Treatment Market During the Forecast Period
Figure 16 Asia Pacific to Register the Highest Growth in the Forecast Period
Figure 17 Global Market: Drivers, Restraints, Opportunities, and Challenges
Figure 18 Declining Global Fertility Rate (1960–2016)
Figure 19 Global Market, By Product, 2018 vs 2023 (USD Million)
Figure 20 Global Market, By Procedure, 2018 vs 2023 (USD Million)
Figure 21 Female Infertility Treatment Segment to Dominate the Market During the Forecast Period
Figure 22 Global Market, By End User, 2018 vs 2023 (USD Million)
Figure 23 Global Market, By Region, 2018 vs 2023 (USD Million)
Figure 24 North America: Infertility Treatment Market Snapshot
Figure 25 Europe: Infertility Treatment Market Snapshot
Figure 26 Asia Pacific: Infertility Treatment Market Snapshot
Figure 27 The Cooper Companies Held the Leading Position in the Infertility Treatment Market, 2017
Figure 28 Hamilton Throne Ltd.: Company Snapshot
Figure 29 The Cooper Companies: Company Snapshot
Figure 30 Thermo Fisher Scientific: Company Snapshot
Figure 31 Vitrolife: Company Snapshot
Figure 32 Zeiss Group: Company Snapshot

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
5 of 5
  • Cook Group Incorporated
  • Esco Micro Pte. Ltd.
  • Genea Limited
  • Hamilton Throne, Ltd.
  • Ihmedical A/S
  • Irvine Scientific (A Member of Jx Holdings Group)
  • IVFTech Aps
  • Kitazato Corporation
  • Medgyn Products, Inc.
  • Rocket Medical PLC
  • Somatex Medical Technologies GmbH
  • The Baker Company, Inc.
  • The Cooper Companies, Inc.
  • Thermo Fisher Scientific
  • Vitrolife Ab
  • Zeiss Group
Note: Product cover images may vary from those shown
Adroll
adroll